Literature DB >> 28750253

Associations between butane hash oil use and cannabis-related problems.

Madeline H Meier1.   

Abstract

BACKGROUND: High-potency cannabis concentrates are increasingly popular in the United States, and there is concern that use of high-potency cannabis might increase risk for cannabis-related problems. However, little is known about the potential negative consequences of concentrate use. This study reports on associations between past-year use of a high-potency cannabis concentrate, known as butane hash oil (BHO), and cannabis-related problems.
METHODS: A sample of 821 college students were recruited to complete a survey about their health and behavior. Participants who had used cannabis in the past year (33%, n=273) completed questions about their cannabis use, including their use of BHO and cannabis-related problems in eight domains: physical dependence, impaired control, academic-occupational problems, social-interpersonal problems, self-care problems, self-perception, risk behavior, and blackouts.
RESULTS: Approximately 44% (n=121) of past-year cannabis users had used BHO in the past year. More frequent BHO use was associated with higher levels of physical dependence (RR=1.8, p<0.001), impaired control (RR=1.3, p<0.001), cannabis-related academic/occupational problems (RR=1.5, p=0.004), poor self-care (RR=1.3, p=0.002), and cannabis-related risk behavior (RR=1.2, p=0.001). After accounting for sociodemographic factors, age of onset of cannabis use, sensation seeking, overall frequency of cannabis use, and frequency of other substance use, BHO use was still associated with higher levels of physical dependence (RR=1.2, p=0.014).
CONCLUSIONS: BHO use is associated with greater physiological dependence on cannabis, even after accounting for potential confounders. Longitudinal research is needed to determine if cannabis users with higher levels of physiological dependence seek out BHO and/or if BHO use increases risk for physiological dependence.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Butane hash oil; Cannabis; Cannabis dependence; Concentrate; Dabs; Marijuana

Mesh:

Substances:

Year:  2017        PMID: 28750253     DOI: 10.1016/j.drugalcdep.2017.06.015

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  24 in total

1.  Initiation of vaporizing cannabis: Individual and social network predictors in a longitudinal study of young adults.

Authors:  Rachel N Cassidy; Matthew K Meisel; Graham DiGuiseppi; Sara Balestrieri; Nancy P Barnett
Journal:  Drug Alcohol Depend       Date:  2018-05-19       Impact factor: 4.492

2.  Associations Between Cannabis Use and Cardiometabolic Risk Factors: A Longitudinal Study of Men.

Authors:  Madeline H Meier; Dustin Pardini; Jordan Beardslee; Karen A Matthews
Journal:  Psychosom Med       Date:  2019-04       Impact factor: 4.312

3.  Leveraging user perspectives for insight into cannabis concentrates.

Authors:  Patricia A Cavazos-Rehg; Melissa J Krauss; Shaina J Sowles; Glennon M Floyd; Elizabeth S Cahn; Veronica L Chaitan; Marisel Ponton
Journal:  Am J Drug Alcohol Abuse       Date:  2018-03-07       Impact factor: 3.829

4.  Frequently asked questions about dabbing concentrates in online cannabis community discussion forums.

Authors:  Meredith C Meacham; Shim Roh; Jamie Suki Chang; Danielle E Ramo
Journal:  Int J Drug Policy       Date:  2019-08-07

Review 5.  Changing landscape of cannabis: novel products, formulations, and methods of administration.

Authors:  Tory R Spindle; Marcel O Bonn-Miller; Ryan Vandrey
Journal:  Curr Opin Psychol       Date:  2019-04-09

6.  A Twitter-based survey on marijuana concentrate use.

Authors:  Raminta Daniulaityte; Mussa Y Zatreh; Francois R Lamy; Ramzi W Nahhas; Silvia S Martins; Amit Sheth; Robert G Carlson
Journal:  Drug Alcohol Depend       Date:  2018-04-11       Impact factor: 4.492

7.  Negative marijuana-related consequences among college students in five countries: measurement invariance of the Brief Marijuana Consequences Questionnaire.

Authors:  Adrian J Bravo; Matthew R Pearson; Angelina Pilatti; Laura Mezquita
Journal:  Addiction       Date:  2019-07-08       Impact factor: 6.526

8.  Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial.

Authors:  Tom P Freeman; Chandni Hindocha; Gianluca Baio; Natacha D C Shaban; Emily M Thomas; Danica Astbury; Abigail M Freeman; Rachel Lees; Sam Craft; Paul D Morrison; Michael A P Bloomfield; Dominic O'Ryan; Jane Kinghorn; Celia J A Morgan; Ali Mofeez; H Valerie Curran
Journal:  Lancet Psychiatry       Date:  2020-07-28       Impact factor: 27.083

9.  Effects of daily Δ9-Tetrahydrocannabinol (THC) alone or combined with cannabidiol (CBD) on cognition-based behavior and activity in adolescent nonhuman primates.

Authors:  Sarah L Withey; Brian D Kangas; Sophia Charles; Andrew B Gumbert; Jessica E Eisold; Susan R George; Jack Bergman; Bertha K Madras
Journal:  Drug Alcohol Depend       Date:  2021-02-17       Impact factor: 4.492

10.  Changes in Cannabis Consumption Among College Students During COVID-19.

Authors:  Jennifer E Merrill; Angela K Stevens; Kristina M Jackson; Helene R White
Journal:  J Stud Alcohol Drugs       Date:  2022-01       Impact factor: 2.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.